Thanks for the heads up from Aaron Wininger of Schwegman
Lundberg & Woessner, the first drug patent linkage decision has
been decided by the Beijing IP Court (see announcement). There does
not seem
to be news from the competing CNIPA of the CNIPA's drug patent
linkage decision, although the CNIPA has accepted a lot more cases
than the Beijing IP Court (12 for CNIPA, 1 for Beijign IP
Court).
mp.weixin.qq.com/s/-9SocP2TLE20Xw7me3OxNw
Further details of the above announcement are as below. As
reported previously (see my post
https://www.linkedin.com/feed/update/urn:li:activity:6859816088893583360?commentUrn=urn%3Ali%3Acomment%3A%28activity%3A6859816088893583360%2C6864391360473104385%29),
the details of the case is as below:
